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1015-9584/Copyright ª 2015, Asian SuSummary Background: Laparoscopic sleeve gastrectomy (LSG) is a popular stand-alone bar-
iatric surgery, despite a paucity of long-term data. Hence, this study is to report the long-term
outcome of LSG as primary bariatric procedure and the result of revisional surgery.
Methods: With retrospective analysis of a prospective bariatric database, participants who de-
faulted clinic follow-up were interviewed by telephone. A total of 667 LSG was performed as
primary bariatric procedure (2006e2012) with mean age of 34.5  9.7 years old, female 74.7%,
mean body mass index (BMI) 37.3  8.1 kg/m2. A 36-F bougie was used for all cases.
Results: There were 61 patients available with long-term data. The weight loss outcome at 1
year, 2 years, 3 years, 4 years, and 5 years showed a mean BMI 26.3, 25.2, 25.3, 27.1, and 26.2
with mean excess weight loss (EWL) 76.0%, 79.6%, 77.3%, 73.4%, and 72.6% respectively. How-
ever, 17% patients developed de novo gastro-esophageal reflux disease (GERD). Eighteen pa-
tients (2.2%) needed surgical revisions due to weight regain (n Z 6), persistent type 2
diabetes mellitus (T2DM; n Z 2), stricture (n Z 2), and GERD (n Z 8). The revision resulted
in an additional mean excess weight loss of 23.8% with mean BMI 24.9 kg/m2 at 6 months post-
operatively. There was a 23.7% mean reduction of HbA1c with one patient who was in complete
diabetic remission at 1 year.
Conclusion: Our results showed LSG is a durable bariatric procedure with > 70% EWL at 5 years
despite a high incidence of GERD. The need for revision of LSG is low and mainly for GERD.
Copyright ª 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.ave no conflicts of interest.
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22 E.-H. Pok et al.1. IntroductionLaparoscopic sleeve gastrectomy (LSG) has been gaining
popularity as a stand-alone bariatric surgery worldwide
since the first inception of this novel procedure in 1988. It
was first described as the initial step, as part of bil-
iopancreatic bypass with duodenal switch (DS) for obesity
by Dr. Doug Hess1 in March 1998. In a similar development,
Dr. Gagner et al2 used it as a first stage bariatric procedure
for high risk patients in order to reduce the risk profile of
patient, and later performed gastric bypass once adequate
weight loss was achieved. However, it was noted that the
sleeve gastrectomy alone could cause good weight loss
before the second procedure. In fact, this finding was
consistent with other published reports.3,4 Due to its
effectiveness in weight loss and resolution of comorbid-
ities, it was then used as the primary restrictive bariatric
procedure and verified in three International Consensus
Summit of Sleeve Gastrectomy in 2007, 2009, and 2011 as a
safe and feasible primary bariatric procedure.5e7 In fact,
the American College of Surgeons Bariatric Surgery Center
Network has put it in the intermediate position between
laparoscopic gastric banding and laparoscopic gastric
bypass in terms of reduction of body mass index (BMI),
complication rates, and resolution of obesity related
illness.8
However, until now, the technique of LSG is still not
standardized. This is because, different bougie sizes have
been used to calibrate the diameter of the sleeve and
variation of technical approaches might have led to
different results from this procedure. At the moment,
despite the paucity of long-term outcomes, sleeve gas-
trectomy has gained wide acceptance by patients based on
the short and medium term data. In addition, with the
expanding field of bariatric surgery and misconception of
laparoscopic sleeve gastrectomy as an easier operation, the
complication rate and the need of revisional surgery for
complicated or failed primary LSG would be expected to
increase especially in the hands of inexperienced surgeons.
Therefore, the aim of this study is to report our 7 years
experiences of LSG in Asia as a primary bariatric procedure
regarding the short- and long-term clinical outcomes
especially in the maintenance of effective weight loss. It is
also necessary to know the cause of failure of LSG as well as
the indications and outcomes following revisional surgery
for LSG. Key variations of surgical techniques over the years
is also described in our practice.2. Materials and methods
We performed a retrospective review of patients who un-
derwent LSG from 2006 to 2012 who have completed at
least 6 months follow-up. Informed consent was taken from
all patients and data were collected prospectively into a
database which was later analyzed retrospectively. The
baseline characteristic, surgical outcome, weight loss and
comorbidity resolution, and revisional surgery were
included for this analysis. Patients who had surgery > 5
years ago but defaulted follow-up, were contacted by
telephone to enquire upon their weight status and reflux
symptoms. A total of 667 LSG was performed as the primarybariatric procedure. The patients’ mean age was 34.5  9.7
years (range 14e71 years) with a female dominant cohort of
74.7%. The preoperative mean BMI was 37.3  8.1 kg/m2
(range 20.8e75.3 kg/m2) with mean excess weight
41.7  23.3 kg.
Effectiveness end points include BMI, percentage of
excess weight loss (% EWL) from baseline to 6 months and
yearly with trend up to 7 years. Safety end points were
defined by the 30 days perioperative major and minor
complications after surgery.
The indication for revision of LSG was examined. Failure
of primary procedure is defined as inadequate weight loss
(< 50% EWL) or weight regain (> 10 kg body weight), or
failure of resolution of diabetes mellitus. Complicated LSG
is defined as long-term side effects secondary to sleeve
gastrectomy such as GERD. Surgery for treatment of peri-
operative complications occurring within 30 days after
primary surgery were not included in the analysis for revi-
sional surgery.2.1. Surgical technique
Our surgical technique of sleeve gastrectomy has evolved
over the years with reinforcement suture and invagination
of the stapler line which was introduced in 20069 and
reduced ports access surgery started in 2009 as previously
reported.10 Subsequently, we used the transumbilical two
site modified single incision laparoscopic surgery (SILS)
technique for all LSG.
Important surgical techniques are briefly described. All
procedures were completed laparoscopically. Three skin
incisions were placed at two sites of the abdomen,
including two skin incisions along the natural fold of um-
bilicus for 10-mm port for videoscope and a 12-mm port for
the left working port, and one skin incision at left lateral
abdominal wall for a 5-mm port as right working port. A 2-
mm Kircher wire was used as liver retractor and inserted
through a subxiphoid skin puncture for exposition of the
angle of His. The greater omentum and short gastric ar-
teries were dissected by using 5-mm blunt tip laparoscopic
Ligasure (Covidien, Norwalk, CT, USA) system, starting at
4 cm from pylorus (2nd branch of right gastro-epiploic ar-
tery) to the angle of His sparing the sling fibers near cardio-
esophageal junction and gastro-epiploic vessels. A large fat
pad at an angle of His was dissected to provide a clean field
for gastric fundus resection. Meticulous dissection was
performed at the angle of His with full mobilization of the
gastric fundus. The posterior wall of the stomach was freed
from the pancreatic adhesion if present. Once the stomach
was completely mobilized, an oro-gastric tube size 36 F was
placed along the lesser curvature of stomach directed to-
ward the pylorus as a calibrator before starting the gastric
resection. Vertical transection of the stomach was accom-
plished with five to six firings of a 60-mm linear stapler
(Endo GIA, Covidien, Norwalk, CT, USA). The firing stapler
height was determined by thickness of the gastric tissue,
using a green (4.1 mm) or black (4.4 mm) stapler near the
antrum and a blue (3.5 mm) stapler for the rest of the
gastric resection. The important technical details during
the gastric transection includes symmetrical lateral trac-
tion of the stomach to ensure an equal proportion of the
Long-term outcome of sleeve gastrectomy 23anterior and posterior walls were included in each firing of
the staplers; avoiding a spiral stapler line and minimal 1-cm
margin of gastric fundus from the angle of His to avoid a
critical vascular area in the cardio-esophageal junction.
After gastric resection, the long gastric remnant stapler
line was invaginated with a 3-0 vicryl suture to prevent
leakage and hemorrhage. However, with the introduction of
our technique of sleeve gastrectomy and gastric plication, a
nonabsorbable suture was used instead for plication of the
stapler line with a 36-F bougie inside. The gastric tube was
then fixed to the posterior peritoneal tissue to prevent
gastric volvulus. No intraoperative leak test was employed
and no drain was used routinely. The resected stomach was
extracted through the umbilical incision after dilatation
without using endobag. The fascial defect was closed with a
vicryl suture or plugged with surgicel (Surgicel Hemostat
(Johnson & Johnson, Arlington, TX)).11
3. Results
3.1. Outcome of primary sleeve gastrectomy
3.1.1. Surgical outcome
The mean surgical time for LSG was 117  34.5 minutes
with median blood loss of 30 mL. The average length of
postoperative stay was 3.5  3.4 days. The overall post-
operative 30 days morbidity rate was minor 5.5% (n Z 37)
and major 3.1% (nZ 20) respectively as showed in Table 1.
Fifteen cases needed reoperation due to leakage (nZ 11),
major bleeding (nZ 1), bowel injury (nZ 2), and port site
hernia (n Z 1). There was one patient who underwent LSG
in 2006 during the learning curve developed gastric tube
stricture which resolved with endoscopic dilatation. There
were 14 postoperative leaks detected in our large seriesTable 1 Surgical outcome and perioperative complication with
Parameter Mean  SD/n Management
Surgical duration (min) 117  34.5
Estimated blood loss (mL) 30a
Postoperative stay (d) 3.5  3.4
Time to flatus (d) 1.7  0.6
Perioperative complication
Major
Leakage 14 11 reoperati
1 converted
Major bleeding 1 Reoperation
Stricture 1 Endoscopic d
Bowel injury 2 1 small bowe
Cardiac failure 1 Medical care
Port site hernia 1 Reoperation
Minor
Abdominal wall abscess 1 Wound care
Subcutaneous hematoma 3 Wound care
Wound infection 17 Wound care
Minor bleeding 15 Blood transfu
Pneumonia 1 Medical care
RYGB Z Roux-en-Y gastric bypass.
a Median.(2.1%). However, the risk of leak was highly influenced by
the learning curve of surgeons as most of the leak occurred
in the first 100 cases (9%), dropped to 1e2% for the subse-
quent 300 cases. There was no more postoperative leakage
noted for the recent 300 cases in our series (0%). For the
management of leakage as shown in Table 1, three cases
with minor leak healed with conservative management; 11
cases needed reoperation for wash-out and insertion of
drains for drainage. However, two cases required additional
endoscopic stenting due to high leakage at the cardio-
esophageal junction. All leaks healed subsequently except
one case of high leakage at the cardio-esophageal junction
eventually needed conversion to Roux-en-Y gastric bypass
(RYGB) after 6 months due to chronic fistula. There was
only one mortality (0.13%) due to undiagnosed obstructive
sleep apnea. The patient developed respiratory failure
immediately after surgery which required ventilation in
intensive care unit (ICU) but died on the same day.
3.1.2. Weight loss and comorbidity outcome
Postoperatively, the mean BMI for 6 months, 1 year, 2 years,
3 years, 4 years, and 5 years were 28.9, 26.3, 25.2, 25.3,
27.9, and 26.2, with a mean % EWL of 64.2%, 76.0%, 79.6%,
77.3%, 73.4%, and 71.6% respectively (Table 2). The evolu-
tion of overall BMI change is depicted in Fig. 1A. However,
the effect of LSG was more pronounced in lower BMI pa-
tients (< 35 kg/m2) throughout a 5 year period. In 5 years,
the % EWL was up to 80% for BMI < 35 kg/m2, but it was
slightly lower for BMI 35e50 kg/m2 and BMI > 50 kg/m2,
which was 64.7% and 71.8% respectively. (Fig. 1B) The
maximal weight loss was achieved within 2 years but
showed small weight regain subsequently. Although the
number of follow-up patients for 6 years (n Z 19) and 7
years (nZ 12) were lesser, the effective weight loss effect
still maintain beyond 70% EWL with BMI < 30 kg/m2in 30 days.
on with drain insertion, 2 required stenting to due high leak,
to RYGB
due to intraabdominal bleeding
ilatation
l injury with repair, 1 colon injury required colectomy
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Figure 1 Weight loss progress postLSG over 7 years in
different BMI groups (A) overall BMI change and (B) % EWL. %
EWLZ percentage excess weight loss; BMIZ body mass index;
LSG Z laparoscopic sleeve gastrectomy.
24 E.-H. Pok et al.All obesity related comorbidities decreased significantly
after surgery in 1 year. There was > 90% reduction of the
prevalence of diabetes in our cohort. Conversely, 17% (5/
29) of the patients developed de novo GERD in 5 years
follow-up and required long-term proton-pump inhibitor.
Out of 667 patients who underwent LSG, 27 were oper-
ated in 2006, 41 in 2007; 51 in 2008; 50 in 2009; 95 in 2010;
163 in 2011; and 239 in 2012. This showed that LSG has
become an important bariatric procedure and represents
50% of the bariatric workload in our unit currently. Never-
theless, there has been a declining trend in the number of
patients returning for clinic follow-up over the years. In 5
years, only nine (7.6%) out of a total 119 patients were able
to return to clinic for long-term follow-up. Through tele-
phone interviews, the follow-up data of 61 patients (51.2%)
were available at 5 years.
3.2. Outcome of revisional surgery
With regard to revisional procedure after primary LSG, a
total 18 patients (2.3%) needed surgical revision due to
various reasons: weight regain (n Z 6), persistent type 2
diabetes (n Z 2), stricture (n Z 2), and GERD (n Z 8). All
revisions were performed laparoscopically. The type of
revisional procedure performed were RYGB (nZ 16) and DS
Long-term outcome of sleeve gastrectomy 25(n Z 2) with a median time to revision of 33 months (range
3e62 months). The earliest intervention (3 months) was for
a patient who had persistent vomiting due to the gastric
tube stricture. The mean surgical time for revisional surgery
was 152.2 minutes (range 95e205 minutes) with average
blood loss of 30 mL (range 20e70 mL). The postoperative
stay was short at 3.7 days (range 2e7 days). There was only
one minor complication due to wound infection and no
major complications occurred in our revision series. All
symptoms (stricture and GERD) due to complicated LSG
resolved immediately after surgery. For patients with weight
regain (prerevision BMI 34.9 kg/m2), the revisional surgery
resulted in mean excess weight loss of 54.0% with mean BMI
24.9 kg/m2 at 6 months postoperatively. For patients with
poor glycemic control (n Z 2), there was a 23.7% mean
reduction of HbA1c with one patient in complete remission
without medication in 1 year.4. Discussion
This study has confirmed the long-term efficacy of LSG as a
stand-alone bariatric procedure. Our long-term results over
5 years has shown that primary LSG resulting in > 70%
average % EWL. This result concurs with recent publications
which showed > 50% EWL in long-term results,12e20 as
shown in Table 3.12e21 Nine of these reports were from
Western countries and two were from Asia including the
present study. However, our study reported greater weight
loss which might be due to our cohort of patients having a
lower BMI (37.3 kg/m2), thus resulting in greater efficacy of
weight loss as compared with other series. Besides, we used
a smaller bougie size, 36 F for calibration to make a tighter
sleeve which may have facilitated greater weight loss.
However, if we correlate the % EWL with different BMI
groups, the lower BMI patients (< 35 kg/m2) seemed to
derive greater weight loss as compared with higher BMI
patients (Fig. 1B). However, the use of % EWL might be
exaggerated in lower BMI patient as it depends on the pa-
tient’s initial BMI as a relative measure. The heavier the
patient, the smaller the % EWL, and vice versa. Further
studies are required to find a more suitable parameter for
weight loss results for the outcome of bariatric surgery.Table 3 Long-term results of sleeve gastrectomy in literature a
Study n Bougie size, F Follow-up
Rawlins et al16 (2013) 49 24 5
Weiner et al19 (2007) 8 32, 44 5
Strain et al18 (2011) 23 40 5
Catheline et al13 (2013) 45 34 5
Bohdjalian et al12 (2010) 21 48 5
Sarela et al17 (2012) 13 32 8þ
D’Hondt et al14 (2011) 23 30 6
Himpens et al15 (2010) 30 34 6þ
Braghetto et al21 (2012) 60 NA 5
Zachariah et al20 (2013) 6 36 5
Present study 61 36 5
Data are presented as mean.
% EWL Z percentage excess weight loss; BMI Z body mass index; GEOur results showed the maximal weight loss occur within
2 years after surgery with tendency for weight regain later
in our series. Similarly, Braghetto et al21 reported weight
regain was observed in 30% of patients with the trend
starting after the third year of surgery. The reasons for
weight regain could be due to factors such as gastric tube
dilatation or changes in eating habit by shifting toward
“easy” highly caloric food.22 It has been suggested different
gastric tube sizes would affect the effect of weight loss.
The smaller the sleeve gastric lumen, the less likely for
gastric tube dilatation19 based on Laplace’s law but it might
be associated with higher complication rates such as GERD,
leaks, and strictures.23 The recent consensus regarding the
optimal bougie size for LSG were 32e36 F for final cali-
bration.23 The second consideration is the complete
removal of gastric fundus, the site of production of hor-
mone ghrelin as it will increase postprandial sensation of
satiety after meals, thus maintaining the effect of long-
term sustainable weight loss. Furthermore, the role of
ghrelin effect has been strongly supported by an animal
experimental study which showed that replacement of
ghrelin in gastrectomy mice would lead to weight regain.24
Despite all these technical considerations, the most
important modality for durable weight loss still relies on
patients’ compliance with good eating habits as weight
recidivism would occur in any bariatric surgery.25 Avoiding
easy calorie dense food with a good lifestyle is the corner
stone for long-term weight loss. Therefore, continued pa-
tient education within multidisciplinary teams is important
for the success of any bariatric program.
With effective weight loss, most of the obesity-related
comorbidities were significantly reduced in our series
especially diabetes mellitus. Although any effective weight
loss would lead to better glycemic effects due to reduced
systemic inflammatory response and improvement of insu-
lin sensitivity, LSG might have metabolic reduction effect
as studies have shown it has hormonal effects with raised
peptides YY and GLP-1.26,27 Melissas et al28 further
explained the incretins effect might be due to early and
prolonged stimulation of intestinal L cells due to the
extension of food contact time with the area of the ter-
minal ileum occurs after LSG with short bowel transit, thus
enhancing the glycemic control.ccording to decreasing order of initial BMI.
, y Initial BMI BMI at follow-up % EWL %GERD
65.0 NA 86.0 11.0
60.7 45.0 NA NA
52.2 40.0 NA NA
49.1 35.4 50.7 33.3
48.2 NA 55.0 30.8
45.8 NA 68.0 NA
39.3 NA 55.9 NA
39.0 31.1 53.3 23.0
38.4 29.9 57.3 27.5
37.4 27.9 63.7 NA
37.3 26.2 72.6 17.0
RD Z gastro-esophageal reflux disease; NA Z not available.
26 E.-H. Pok et al.The surgical risk of LSG has decreased dramatically after
the learning curve. Our series showed high incidence of
leaks in the first 100 cases (9%) but low leakage rates in
subsequent series due to improved surgical techniques. The
formation of long and narrow gastric tubes will cause
stricture if the gastric tube is sleeved too narrow at the
incisura angularis angle. Usually endoscopic dilatation is
effective at relieving the stricture but in difficult cases with
long stricture, revision with roux-en Y gastric bypass is
needed.29 Besides, laparoscopic seromyotomy of stricture
areas has been used with good outcomes.30 Furthermore,
we recognized that the slim gastric tube tend to coil
medially once formed which would aggravate the severity
of strictures, therefore it is essential to fix the gastric tube
to the retroperitoneal tissue as an L-configuration tube
(Fig. 2).
The main long-term drawback of LSG is the development
of GERD. The available published results on GERD in long-
term results of LSG showed 11e33% reflux rate (Table 3).
Our experience with LSG showed de novo GERD occurred up
to 17% in our long-term series. Although GERD is a complex
disease associated with obesity with proposed pathophysi-
ology due to an increased prevalence of hiatus hernia,
increased intraabdominal pressure, delayed gastric
emptying, and dysfunctioning of the lower esophageal
sphincter. However, the relationship between sleeve gas-
trectomy and GERD is intriguing as various studies reported
that it either improves or worsens reflux symptoms after
surgery. Chiu et al31 reported a systemic review on sleeve
gastrectomy on GERD which did not show any conclusive
relationships on both of them. As the stapling of fundus
near the angle of His which would usually disrupt the
cardio-esophageal junction, it is logical to expect the
prevalence of GERD will be higher in combination with high
intragastric pressure after surgery. Besides, alterations in
gastric emptying after LSG could be potentially important
in determining its effect on GERD. However, the study of
sleeve gastrectomy on gastric emptying is conflicting28,32,33
which might be due to different surgical techniques used.
Recently, there was a suggestion that a combination of
dilated upper part of the sleeve with a relative narrowing of
the midstomach, without complete obstruction, might
contribute to GERD after sleeve gastrectomy.34 This func-
tional obstruction would result in severe esophageal dys-
motility with reflux symptom. However, patients who had
sleeve gastrectomy with concomitant repair of hiatalFigure 2 Fixation of gastrichernia (HH) were found to have reduced incidence of GERD
after surgery.35 The argument is that the presence of HH
could further impair the antireflux mechanisms, worsening
the severity of GERD. Therefore, currently it is recom-
mended and essential to look for hiatal defects and repair it
during sleeve gastrectomy.23 Based on our experience,
small hiatal defects could be missed at preoperative
endoscopy or upper gastrointestinal contrast study. How-
ever, with careful examination of the crura and proper
dissection of the left crura during dissection of the angle of
His, the small crural defect would be revealed easily.
Long-term revisional rates of LSG is lower than the pre-
vious experience of laparoscopic gastric banding and lapa-
roscopic vertical banded gastroplasty, and similar to gastric
bypass. Our result demonstrated the revision rate for LSG
was low (2.2%). Most of the revisions were for intractable
GERD or weight regain. As LSG is seen as a restrictive pro-
cedure, some weight regain is also expected in longer
term follow-ups. In patient with weight regain without
reflux symptoms, duodenal-jejunal bypass36 or duodenal
switch is a good option. Although revisional procedures for
weight regain with another restrictive procedures such as
adding gastric banding,37 resleeve gastrectomy38 have been
described, we believe malabsorptive procedures should be
employed instead to prevent further failure. For GERD, the
definitive treatment would be ideally RYGB. Although LSG is
a good procedure for bariatric surgery, the efficacy of dia-
betes remission in lower BMI patient is inferior to the gastric
bypass.39 Similarly, in the Schauer et al study,40 although the
diabetes remission rate was similar between gastric bypass
ad sleeve gastrectomy, 30% of the sleeve patients were on
glycemic agents but none in gastric bypass patients.
Therefore, in patients with persistent diabetes after LSG,
adding a duodenal switch might be a good option based on
themechanism of foregut bypass. Our revision series showed
that low complications could be achieved in experienced
hands. During revision to RYGB, it is important to ensure
good vascularity of proximal gastric tube and refashion the
gastric pouch with larger stapler height due to gastric tube
scarring.
The limitation of this study is its retrospective nature of
analysis and a low clinic follow-up rate (7.6%) in 5 years
outcome data. There was a declining number of patients
returning for clinic follow-ups as most of the patients
achieved the desired weight loss with minimal side effects
or nutrition issues unless complications occurs. In othertube to retroperitoneum.
Long-term outcome of sleeve gastrectomy 27words, they did well with the operation, however, our
practice is diligent with calling patients regularly for
follow-up and auditing the outcome. Although only nine out
of our 119 patients from the 5-years outcome series have
regular clinic follow-ups, we were able to trace 52 patients
by telephone interview, making the total number of 61
(51.2%) patients for 5 years outcome data. In fact, this is
the largest number of follow-up patients for 5 years
outcome data reported so far (Table 3). As most of the
bariatric surgery series15,19 also reported the difficulty of
attaining long-term follow-up, thus it is essential to rein-
force patient commitment of follow-up at least on annual
basis.
5. Conclusion
We report the long-term outcome of primary LSG and its
revision rate. The primary LSG is a safe and durable primary
bariatric procedure with overall 70% EWL at 5 years and
satisfactory resolution of comorbidities. The need of revi-
sion of LSG is low (2.2%) and indicated mainly for refractory
GERD or weight regain with satisfactory outcome. However,
GERD is still a major problem associated with LSG, which is
up to 17% symptoms in 5 years and required further
investigation.Acknowledgments
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